You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 24, 2023

Usl Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for USL PHARMA, and what generic and branded alternatives to USL PHARMA drugs are available?

USL PHARMA has one hundred and three approved drugs.

Summary for Usl Pharma

US Patents:	0
Tradenames:	56
Ingredients:	54
NDAs:	103

Drugs and US Patents for Usl Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Usl Pharma	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	TABLET;ORAL	089123-001	Mar 20, 1986		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Usl Pharma	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	087919-001	Jun 22, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Usl Pharma	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	070203-001	Nov 8, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Usl Pharma	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	072542-001	Feb 1, 1989		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Usl Pharma	ESTRADIOL	estradiol	TABLET;ORAL	040297-003	Apr 17, 2002		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Usl Pharma

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Boehringer Ingelheim

Mallinckrodt

Medtronic

Moodys

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.